Skip to main content
OpenTrials

Clinical trial condition

Adrenal Gland Diseases

Explore clinical trials studying Adrenal Gland Diseases. Study availability and eligibility vary by location and protocol.

527 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Adrenal Gland Diseases trial results

Completed

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

NCT03687242

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +18 more
Locations
  • Spruce Biosciences Clinical Site Orange, California, United States
  • Spruce Biosciences Clinical Site San Diego, California, United States
  • Spruce Biosciences Clinical Site Atlanta, Georgia, United States
  • Spruce Biosciences Clinical Site Indianapolis, Indiana, United States
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.

NCT03231878

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +21 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Hospital de la Pitié-Salpêtrière Paris, France
View Trial Details
Completed

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

NCT05063994

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenogenital Syndrome, +16 more
Locations
  • Diurnal Investigational Site in Los Angeles Los Angeles, California, United States
  • Diurnal Investigational Site in Orange Orange, California, United States
  • Diurnal Investigational Site in Jacksonville Jacksonville, Florida, United States
  • Diurnal Investigational Site in Iowa Iowa City, Iowa, United States
View all 21 locations
View Trial Details
Completed

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

NCT05772169

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, +7 more
Locations
  • Site 407 Escondido, California, United States
  • Site 379 Gardena, California, United States
  • Site 378 Huntington Park, California, United States
  • Site 406 La Jolla, California, United States
View all 36 locations
View Trial Details
Completed

Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

NCT03606408

Conditions
Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, +2 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University School of Medicine G2304 - C2301 Atlanta, Georgia, United States
  • Northwestern University SC - LCI699C2301 Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 56 locations
View Trial Details

Related conditions